Yubo International Biotech Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 351,471 compared to USD 276,689 a year ago. Operating loss was USD 370,085 compared to USD 32,082 a year ago. Net loss was USD 370,008 compared to USD 31,946 a year ago. For the half year, sales was USD 813,800 compared to USD 276,689 a year ago. Operating loss was USD 808,655 compared to USD 172,984 a year ago. Net loss was USD 808,683 compared to USD 172,894 a year ago.